Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Unknown 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 5Breast 5Head & Neck 4Genitourinary 4Gynecologic 2Thoracic 1Sarcoma 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Neoplasms 1High-Risk Cancer 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Radiotherapy, Adjuvant × Genitourinary × Clear all
NCT05445648 2022-12-28

CBPTMI

First Affiliated Hospital Xi'an Jiaotong University

Phase 2 Unknown
65 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00860652 2022-11-18

RAVES

Trans Tasman Radiation Oncology Group

Phase NA Active not recruiting
333 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT04740866 2021-02-09

Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer

Cairo University

Phase NA Unknown
100 enrolled
Genitourinary

High-Risk Cancer

NCT02668718 2016-02-02

Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer

Helsinki University Central Hospital

Phase 3 Unknown
250 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡